Dr Overman is focused on improving the outcomes for patients with pancreatic and intestinal cancers, with a strong interest in clinical trials and translational research. He is a principal investigator on numerous studies investigating immune-checkpoint therapy in gastrointestinal malignancies, and has been involved in various clinical trial studies involving small bowel adenocarcinomas. He has published articles in peer-reviewed journals that include the Journal of Clinical Oncology and Annals of Oncology. Dr Overman earned his MD from Johns Hopkins School of Medicine in Baltimore, Maryland.